Ó£»¨ÊÓƵ

Skip to main content

Table 5 Multivariate analysis (odds ratio, p-value) of risk factors associated with self-reported anxiety among hypertensive patients, Marrakech, Morocco, 2021–2022

From: The silent struggle: assessing anxiety prevalence in Marrakech’s hypertensive population

Ìý

Bivariate analysis

Multivariate analysis

COR (95% CI)

p-value

AOR (95% CI)

p-value

Female sex

2.4 [1.72–3.47]

&±ô³Ù; 0.0001

1.5 [0.90–2.68]

0.10

Age in years

Ìý

0.01

ÌýÌý

 ≥80

0.7 [0.16–3.26]

0.69

1.1 [0.16–8.02]

0.88

 [70–79±Õ

0.8 [0.19–3.17]

0.74

0.8 [0.14–5.35]

0.88

 [60–69±Õ

1.2 [0.29–4.56]

0.82

1.2 [0.20–7.28]

0.81

 [50–59±Õ

1.4 [0.36–5.73]

0.59

1.2 [0.20–7.28]

0.81

 [40–49±Õ

1.7 [0.41–7.08]

0.45

1.6 [0.26–10.1]

0.60

 [29–39±Õ

1

ÌýÌýÌý

Urban area

2.1 [1.50–2.87]

&±ô³Ù; 0.0001

1.8 [1.11–2.87]

0.01

Monthly income ($)

Ìý

0.009

ÌýÌý

 ≤149

6.1 [1.40–26.8]

0.01

2.5 [0.52–12.8]

0.24

 150–199

4.3 [0.98–18.5]

0.05

2.9 [0.59–14.2]

0.18

 200–299

4.1 [0.94–18.2]

0.05

3.3 [0.68–16.3]

0.13

 300–499

5.6 [1.12-28.0]

0.03

3.5 [0.61–20.7]

0.15

 ≥500

1

ÌýÌýÌý

Tobacco consumption

0.5 [0.30–082]

0.004

0.9 [0.39–2.46]

0.97

Alcohol consumption

0.6 [0.30–1.20]

0.13

1.0 [0.34–2.94]

0.98

Stress

Ìý

&±ô³Ù; 0.0001

ÌýÌý

 Intense stress

22.6 [10.9–46.7]

&±ô³Ù; 0.0001

12.4 [5.6–27.2]

&±ô³Ù; 0.0001

 Moderate stress

3.8 [1.90–7.78]

0.0002

2.4 [1.12–5.12]

0.02

 Low stress

1

ÌýÌýÌý

Unsatisfactory physical activity

1.7 [1.26–2.29]

0.0003

1.1 [0.79–1.79]

0.38

Sedentarity

1.2 [0.99–1.70]

0.05

1.0 [0.34–2.94]

0.98

Not consuming five fruits and vegetables a day

1.5 [1.20–2.03]

0.0007

1.4 [1.01–1.97]

0.04

Lack of monitoring hypertension

1.4 [1.04–2.07]

0.02

1.2 [0.81–1.89]

0.31

Lack of social support

2.9 [2.26–3.88]

&±ô³Ù; 0.0001

1.6 [1.17–2.35]

0.004

Presence of comorbidity

1.3 [1.05–1.76]

0.01

0.8 [0.37–1.72]

0.57

Presence of diabetes

1.3 [1.04–1.75]

0.02

1.3 [0.62–2.85]

0.45

Duration of hypertension more than five years

1.3 [1.01–1.70]

0.03

0.9 [0.71–1.36]

0.95

Family history of hypertension

2.4 [1.87–3.25]

&±ô³Ù; 0.0001

2.2 [1.58–3.13]

&±ô³Ù; 0.0001

Lack of autonomy

1.8 [1.18–2.98]

0.008

1.4 [0.66–2.98]

0.37

Pain and physical discomfort

2.2 [1.74-3.00]

&±ô³Ù; 0.0001

1.8 [1.41–2.48]

&±ô³Ù; 0.0001

Reduced mobility

2.3 [1.60–3.40]

&±ô³Ù; 0.0001

1.4 [0.79–2.77]

0.21

Overweigh and obesity

1.6 [1.16–2.31]

0.003

1.0 [0.65–1.57]

0.95

Unsatisfactory patient relationship with the healthcare system

2.4 [1.62–3.59]

&±ô³Ù; 0.0001

1.2 [0.72–2.25]

0.39

Feel the doctor’s willingness to understand the patient’s hypertension concerns

1.8 [1.37–2.31]

&±ô³Ù; 0.0001

1.1 [0.81–1.68]

0.40

Availability of the drug

2.4 [1.86–3.26]

&±ô³Ù; 0.0001

1.2 [0.82-2.00]

0.26

Non-purchase of a drug if it is out of stock

3.0 [2.27–4.08]

&±ô³Ù; 0.0001

1.8 [1.27–2.76]

0.001

Thinking you have a lot of drugs to take

2.5 [1.36–4.86]

0.003

1.4 [0.64–3.25]

0.37

Adverse drug effects

1.5 [1.17–2.08]

0.002

1.1 [0.76–1.63]

0.56

  1. COR Crude odds ratio, AOR Adjusted odds ratio, CI Confidence interval